central nervous system neoplasms

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for

Not yet recruiting
  • High Grade Glioma
  • +10 more
  • 5-Aminolevulinic Acid (5-ALA) Gliolan®
  • Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
  • Guayaquil, Guayas, Ecuador
    Sociedad de Lucha Contra el Cáncer
Apr 28, 2023

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

Recruiting
  • Breast Neoplasms
  • +7 more
  • Canton, Ohio
    Gabrail Cancer Center
Jan 24, 2023

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Stanford, California
  • +24 more
Sep 28, 2022

Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

Recruiting
  • Brain Tumor, Recurrent
  • +3 more
  • Houston, Texas
    Texas Children's Cancer Center
Aug 15, 2022

Neurobehavioral Functioning in Pediatric Brain Tumor Patients

Active, not recruiting
  • Brain Tumor
  • Central Nervous System Neoplasms
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 6, 2022

    CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    Mar 1, 2022

    CNS Tumors, CNS Tumor Trial in Saint Louis (Tc-99m tilmanocept)

    Recruiting
    • Central Nervous System Neoplasms
    • Central Nervous System Tumor
    • Tc-99m tilmanocept
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 28, 2022

    Lymphoma, Non-Hodgkin, CNS Tumors Trial in Trondheim (18F-FDG, 18F-fluciclovine, standard MRI)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Central Nervous System Neoplasms
    • 18F-FDG
    • +2 more
    • Trondheim, Norway
      Norwegian University of Science and Technology, Department of Ci
    Dec 15, 2021

    CNS Tumors, Pediatric Cancer, GEN1 Gene Mutation Trial in Brno, Prague (FoundationOneHeme)

    Recruiting
    • Central Nervous System Neoplasms
    • +3 more
    • FoundationOneHeme
    • Brno, Czechia
    • +1 more
    Apr 23, 2021

    CNS Tumors Trial (Artificial Intelligence, Practicing Pathologists, Gold Standard)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • Artificial Intelligence
    • +2 more
    • (no location specified)
    Dec 15, 2020

    Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)

    Completed
    • Glioblastoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 3, 2020

    Biomarker Analysis of Central Nervous System Tumors

    Terminated
    • Central Nervous System Neoplasms
    • +4 more
      • Bethesda, Maryland
        National Cancer Institute (NCI), 9000 Rockville Pike
      Nov 16, 2019

      Brain Tumors, CNS Tumors Trial in Houston (TPI287, Bevacizumab)

      Terminated
      • Brain Neoplasms
      • Central Nervous System Neoplasms
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      May 14, 2019

      MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS

      Completed
      • Central Nervous System Diseases
      • Central Nervous System Neoplasms
      • Sarasota, Florida
        Sarasota Memorial Hospital
      Jul 16, 2018

      CNS Tumors, Head and Neck Tumors Trial in Philadelphia (EPO906 (epothilone B))

      Completed
      • Central Nervous System Neoplasms
      • Head and Neck Neoplasms
      • EPO906 (epothilone B)
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      Jul 13, 2018

      Brain Cancer, Head Neck Cancer, Cervix Cancer Trial in Philadelphia (Velcade (bortezomib))

      Completed
      • Brain Cancer
      • +3 more
      • Velcade (bortezomib)
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      May 5, 2017

      Brain Cancer, Arthritis, Rheumatoid, CNS Tumors Trial in Los Angeles, Stanford ([18F]FHBG)

      Completed
      • Brain Cancer
      • +3 more
      • [18F]FHBG
      • Los Angeles, California
      • +1 more
      Mar 12, 2017

      Contrast Agents for MRI Perfusion Analysis in Brain Tumor

      Terminated
      • Central Nervous System Neoplasms
        • Omaha, Nebraska
          UNMC/Nebraska Medicine
        Feb 22, 2017

        Retrospective Study of MRI in Pediatric Patients

        Completed
        • Central Nervous System Disease
        • Central Nervous System Neoplasms
        • Gadobenate Dimeglumine
        • (no location specified)
        Jul 18, 2016

        Combined O-(2-[18F]Fluoroethyl)-L-tyrosine Positron Emission

        Unknown status
        • Glioblastoma
        • +8 more
          • Munich, Bavaria, Germany
            University of Munich, Dep. of Radiation Oncology
          Dec 17, 2012

          Coproporphyrine Isomers and Methotrexate Elimination

          Completed
          • Central Nervous System Neoplasms
          • +3 more
            • Paris, France
            • +1 more
            Jul 30, 2012

            CNS Tumors, Tumor Metastasis Trial in Boston (Temozolomide)

            Terminated
            • Central Nervous System Neoplasms
            • Neoplasm Metastasis
            • Boston, Massachusetts
              Tufts Medical Center
            Apr 26, 2012